238 related articles for article (PubMed ID: 35562149)
21. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
[TBL] [Abstract][Full Text] [Related]
22. Detection of brain somatic variation in epilepsy-associated developmental lesions.
Bedrosian TA; Miller KE; Grischow OE; Schieffer KM; LaHaye S; Yoon H; Miller AR; Navarro J; Westfall J; Leraas K; Choi S; Williamson R; Fitch J; Kelly BJ; White P; Lee K; McGrath S; Cottrell CE; Magrini V; Leonard J; Pindrik J; Shaikhouni A; Boué DR; Thomas DL; Pierson CR; Wilson RK; Ostendorf AP; Mardis ER; Koboldt DC
Epilepsia; 2022 Aug; 63(8):1981-1997. PubMed ID: 35687047
[TBL] [Abstract][Full Text] [Related]
23. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
[TBL] [Abstract][Full Text] [Related]
24. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
Mühlebner A; Coras R; Kobow K; Feucht M; Czech T; Stefan H; Weigel D; Buchfelder M; Holthausen H; Pieper T; Kudernatsch M; Blümcke I
Acta Neuropathol; 2012 Feb; 123(2):259-72. PubMed ID: 22120580
[TBL] [Abstract][Full Text] [Related]
25. A distinct clinicopathological variant of focal cortical dysplasia IIId characterized by loss of layer 4 in the occipital lobe in 12 children with remote hypoxic-ischemic injury.
Wang DD; Piao YS; Blumcke I; Coras R; Zhou WJ; Gui QP; Liu CC; Hu JX; Cao LZ; Zhang GJ; Lu DH
Epilepsia; 2017 Oct; 58(10):1697-1705. PubMed ID: 28833053
[TBL] [Abstract][Full Text] [Related]
26. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
Winawer MR; Griffin NG; Samanamud J; Baugh EH; Rathakrishnan D; Ramalingam S; Zagzag D; Schevon CA; Dugan P; Hegde M; Sheth SA; McKhann GM; Doyle WK; Grant GA; Porter BE; Mikati MA; Muh CR; Malone CD; Bergin AMR; Peters JM; McBrian DK; Pack AM; Akman CI; LaCoursiere CM; Keever KM; Madsen JR; Yang E; Lidov HGW; Shain C; Allen AS; Canoll PD; Crino PB; Poduri AH; Heinzen EL
Ann Neurol; 2018 Jun; 83(6):1133-1146. PubMed ID: 29679388
[TBL] [Abstract][Full Text] [Related]
27. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
[TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
Wong M
Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
[TBL] [Abstract][Full Text] [Related]
29. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
Lim JS; Lee JH
BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
[TBL] [Abstract][Full Text] [Related]
30. [Advances of pathological research and classification in malformations of cortical development associated with refractory epilepsy].
Fu YJ; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):419-424. PubMed ID: 38678320
[TBL] [Abstract][Full Text] [Related]
31. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
32. Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial.
Blümcke I; Coras R; Busch RM; Morita-Sherman M; Lal D; Prayson R; Cendes F; Lopes-Cendes I; Rogerio F; Almeida VS; Rocha CS; Sim NS; Lee JH; Kim SH; Baulac S; Baldassari S; Adle-Biassette H; Walsh CA; Bizzotto S; Doan RN; Morillo KS; Aronica E; Mühlebner A; Becker A; Cienfuegos J; Garbelli R; Giannini C; Honavar M; Jacques TS; Thom M; Mahadevan A; Miyata H; Niehusmann P; Sarnat HB; Söylemezoglu F; Najm I
Epilepsia; 2021 Jun; 62(6):1416-1428. PubMed ID: 33949696
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.
Blümcke I; Thom M; Aronica E; Armstrong DD; Vinters HV; Palmini A; Jacques TS; Avanzini G; Barkovich AJ; Battaglia G; Becker A; Cepeda C; Cendes F; Colombo N; Crino P; Cross JH; Delalande O; Dubeau F; Duncan J; Guerrini R; Kahane P; Mathern G; Najm I; Ozkara C; Raybaud C; Represa A; Roper SN; Salamon N; Schulze-Bonhage A; Tassi L; Vezzani A; Spreafico R
Epilepsia; 2011 Jan; 52(1):158-74. PubMed ID: 21219302
[TBL] [Abstract][Full Text] [Related]
34. mTOR pathway activation in focal cortical dysplasia.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
[TBL] [Abstract][Full Text] [Related]
35. Gradient of brain mosaic RHEB variants causes a continuum of cortical dysplasia.
Lee WS; Baldassari S; Chipaux M; Adle-Biassette H; Stephenson SEM; Maixner W; Harvey AS; Lockhart PJ; Baulac S; Leventer RJ
Ann Clin Transl Neurol; 2021 Feb; 8(2):485-490. PubMed ID: 33434304
[TBL] [Abstract][Full Text] [Related]
36. Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications.
Iffland PH; Crino PB
Annu Rev Pathol; 2017 Jan; 12():547-571. PubMed ID: 28135561
[TBL] [Abstract][Full Text] [Related]
37. Focal cortical dysplasia: Molecular disturbances and clinicopathological classification (Review).
Siedlecka M; Grajkowska W; Galus R; Dembowska-Bagińska B; Jóźwiak J
Int J Mol Med; 2016 Nov; 38(5):1327-1337. PubMed ID: 28025990
[TBL] [Abstract][Full Text] [Related]
38. Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique.
Klein KM; Mascarenhas R; Merrikh D; Khanbabaei M; Maroilley T; Kaur N; Liu Y; Soule T; Manalo M; Tamura G; Jacobs J; Hader W; Pfeffer G; Tarailo-Graovac M
Epilepsia; 2024 Jun; 65(6):1768-1776. PubMed ID: 38587282
[TBL] [Abstract][Full Text] [Related]
39. Review: The international consensus classification of Focal Cortical Dysplasia - a critical update 2018.
Najm IM; Sarnat HB; Blümcke I
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):18-31. PubMed ID: 29359399
[TBL] [Abstract][Full Text] [Related]
40. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
